Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2011
08/25/2011US20110206607 Imidazol (1,2-a)pyridines and related compounds with activity at cannabinoid cb2 receptors
08/25/2011US20110206575 Measurement device for body fluid analysis
08/25/2011US20110206559 Decontamination Method And System Implementing It
08/25/2011US20110206558 Analytical pretreatment device
08/25/2011US20110206557 Biologic fluid analysis cartridge
08/25/2011US20110205079 Flow assurance monitoring
08/25/2011US20110203997 Magnetic separation system comprising flexible magnetic pins
08/25/2011US20110203931 Particle Interrogation Devices and Methods
08/25/2011US20110203927 Method for Measuring Carbon Nanotubes Taken-Up by a Plurality of Living Cells
08/25/2011US20110203925 System and method for coding information on a biosensor test strip
08/25/2011US20110203924 Assay Plates, Reader Systems and Methods for Luminescence Test Measurements
08/25/2011US20110203354 Continuous Testing Method
08/25/2011US20110203353 Systems and methods for evaluating asphaltene deposition inhibitors
08/25/2011US20110203349 Animal Scent Detection Apparatus and System
08/25/2011US20110203174 Method and apparatus for extracting carbon dioxide from air
08/25/2011DE102010054755A1 Method for compaction measurement of soil in building project i.e. road construction project, involves displaying data representing compaction state of parts of material regions over two display regions
08/25/2011DE102010037629A1 Gassensor Gas sensor
08/25/2011DE102010008678A1 Equipment for determining particle in suspensions and solutions, has solar cell connected with voltmeter, and diaphragm and paper diaphragm possessing circular hole in middle part, and sensor formed as solar cell
08/25/2011DE102008029715B4 Kodierungsmodul, Biomessgerät und System zum Betrieb des Biomessgeräts Encoding module, Biomessgerät and system for operating the Biomessgeräts
08/25/2011CA2790684A1 Biomarkers of musculoskeletal disease
08/25/2011CA2790680A1 Alzheimer's disease-specific alterations of protein kinase c epsilon (pkc-epsilon) protein levels
08/25/2011CA2790434A1 Compositions and methods for treating cancer
08/25/2011CA2790290A1 Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosa
08/25/2011CA2790289A1 Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa
08/25/2011CA2790276A1 Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa
08/25/2011CA2790232A1 Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa
08/25/2011CA2790228A1 Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa
08/25/2011CA2790198A1 Subcutaneous glucose sensor
08/25/2011CA2789932A1 Intravascular glucose sensor
08/25/2011CA2789915A1 A pharmaceutical composition of killed cells with substantially retained immunogenicity
08/25/2011CA2789017A1 Oligothiophene derivate as molecular probes
08/25/2011CA2788842A1 Improving activity of fe-s cluster requiring proteins
08/25/2011CA2788006A1 Anti-hpv e7 antibodies
08/25/2011CA2787898A1 Method for the determination of sequence variants of polypeptides
08/25/2011CA2782448A1 Compositions and methods for the detection of antibodies to native human leukocyte antigen
08/24/2011EP2360480A1 Method for measuring low density lipoprotein cholesterol
08/24/2011EP2360479A2 Improved monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
08/24/2011EP2360478A1 Molecular targets and compounds and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
08/24/2011EP2360477A1 Systems, devices and methods for improving accuracy of biosensors using fill time
08/24/2011EP2360476A1 Methods for selecting treatment regimens and predicting outcomes in cancer patients
08/24/2011EP2360475A1 A method and kit for detecting the early onset of renal tubular cell injury
08/24/2011EP2360474A2 Methods and means for treatment of osteoarthritis
08/24/2011EP2360473A1 Compositions and methods for analyzing protein interactions
08/24/2011EP2360472A2 Methods and materials for canine breed identification
08/24/2011EP2360471A1 Method for pre-treating sample containing glycosylated hemoglobin
08/24/2011EP2360470A1 Blood serum or blood plasma separating material and blood-collecting tube using same
08/24/2011EP2360469A1 Method for analyzing metallic material
08/24/2011EP2360465A1 Nitrogen oxide sensing element, nitrogen oxide sensor, nitrogen oxide concentration determination device using same, and method for determining nitrogen oxide concentration
08/24/2011EP2360298A2 Method for depositing a semiconductor nanowire
08/24/2011EP2360277A1 Methods for diagnosing and predicting non-alcoholic steatohepatitis (NASH)
08/24/2011EP2360276A1 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms
08/24/2011EP2360275A1 Oligonucleotide identifiers
08/24/2011EP2360274A1 Compositions and processes for analyte detection; quantification and amplification
08/24/2011EP2360273A1 Compositions and processes for analyte detection; quantification and amplification
08/24/2011EP2360271A1 Decoding of array sensors with microspheres
08/24/2011EP2360269A1 Lupus anticoagulant testing
08/24/2011EP2360268A1 Use of SPLA2 activity for the diagnosis of a cardiovascular event
08/24/2011EP2360267A2 Yeast cell surface display of proteins and uses thereof
08/24/2011EP2360266A2 Yeast cell surface display of proteins and uses thereof
08/24/2011EP2360265A2 Yeast cell surface display of proteins and uses thereof
08/24/2011EP2360264A2 Yeast cell surface display of proteins and uses thereof
08/24/2011EP2360260A1 BASB006 polynucleotide(s) and polypeptides from Neisseria meningitis
08/24/2011EP2360259A2 Promyostatin peptides and methods of using same
08/24/2011EP2360256A1 Method for isolation of soluble polypeptides
08/24/2011EP2360254A1 Assays for screening anti-pd-1 antibodies and uses thereof
08/24/2011EP2360253A1 RNA sequence-specific mediators of RNA interference
08/24/2011EP2360234A1 Microfluidic device and methods of using same
08/24/2011EP2360211A1 Fluorescently-labelled target components
08/24/2011EP2360187A1 Antibodies against HER2 truncated variant CTF-611
08/24/2011EP2360185A2 Administration of agents for the treatment of inflammation
08/24/2011EP2360174A1 HBV core antigen particles with multiple immunogenic components attached via peptide ligands
08/24/2011EP2360169A2 PSMA antibodies
08/24/2011EP2359863A2 Isolation and use of solid tumor stem cells
08/24/2011EP2359857A2 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
08/24/2011EP2359847A1 Modulation of beta-amyloid levels by beta-secretase bace2
08/24/2011EP2359841A2 Survivin-derived peptides and use thereof
08/24/2011EP2359723A1 Decanter lighting and decanter frame
08/24/2011EP2359689A1 Microfluidic device for cell separation and use thereof
08/24/2011EP2359147A1 Device and method for automated verification of the calibration (calibration verification) of an analyzer
08/24/2011EP2359146A1 Non-enzymatic electrochemical method for simultaneous determination of total hemoglobin and glycated hemoglobin
08/24/2011EP2359145A2 Methods for detection and diagnosis of a bone or cartilage disorder
08/24/2011EP2359144A2 Detection and modulation of cytochrome c acetylation
08/24/2011EP2359143A1 Galectin-3 immunoassay
08/24/2011EP2359142A1 Biomarkers
08/24/2011EP2359141A1 Use of foxp2 as a marker for abnormal lymphocytes and as a target for therapy of disorders associated with abnormal lymphocytes
08/24/2011EP2359140A1 Methods for testing binding of a ligand to a g protein-coupled receptor
08/24/2011EP2359139A2 Diagnosis and treatment of autommune diseases by targeting autommune-related b cells ("abcs")
08/24/2011EP2359138A1 Immobilization substrate and method for producing the same
08/24/2011EP2359137A2 Methods for prediction of inflammatory bowel disease (ibd) using serologic markers
08/24/2011EP2359136A1 Fine-grained filler substances for photometric reaction films
08/24/2011EP2359135A1 Method for the identification of carcinogenic compounds
08/24/2011EP2359134A1 Methods for identifying modulating compounds of lymphangiogenesis, means therefore, compounds and uses thereof
08/24/2011EP2359133A1 Determining immunoglobulins in non-blood body fluids of neonatal ungulates
08/24/2011EP2359132A2 Substrate for manufacturing disposable microfluidic devices
08/24/2011EP2359131A1 Device for collecting particles that have a strong electron affinity
08/24/2011EP2359130A1 Determining formation fluid composition
08/24/2011EP2359126A1 Quality inspection of fiber material
08/24/2011EP2359121A2 Systems, apparatus and methods for extending imaging depth range of optical coherence tomography through optical sub-sampling
08/24/2011EP2358912A2 Methods for assessing rna patterns
08/24/2011EP2358871A1 Erk1/2 phosphorylation site specific antibody